The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
170 jobs Number of planned job creations
Announcement Date
1 July 2005
Employment effect (start)
1 February 2008
Foreseen end date
31 July 2008
Description
Europe's biggest pharmaceutical company GlaxoSmithKline announced on 1 July 2005 the expansion of its operations in Dresden. On 19 October 2006 it confirmed that the production of influenza-vaccines is to double in 2008, when a new complex of Glaxo's factory will become operational. This will lead to the creation of 170 jobs. In addition to the built-up of more production capacity, a new vaccine will also be developed in Dresden.
Sources
19 October 2006: Frankfurter Allgemeine Zeitung
2 July 2005: MDR.DE
Citation
Eurofound (2005), GlaxoSmithKline, Business expansion in Germany, factsheet number 61883, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/61883.